glp-1 agonist pharmacology A Comprehensive Review of the Role of Agonists in Weight Management and Their Effect on Metabolic Parameters Such as Blood Glucose, Cholesterol, and Blood Pressure Current Insights, Advantages and Challenges

Frontiers in Microbiology

patients describe a quietening of what many in the clinical community now refer to as food noise, the persistent neurological signal that drives overconsumption independent of genuine caloric need

For instance, the most studied GLP-1 RAs for biosimilar development are liraglutide and semaglutide

Back Baden, A (14 May 2025) 'People who stop weight loss drugs return to original weight within year, analysis finds', The Guardian

GLP-1R agonists effects on cardiovascular events The first pieces of evidence of the potential clinical benefit of GLP-1 agonists have emerged recently, pointing to a decrease of major adverse cardiovascular and cerebrovascular events (MACCE) including stroke, MI, cardiac mortality, acute coronary syndrome, and revascularization procedures

So, 47% more people lose more than 10% of body weight on lifestyle interventions with semaglutide compared to lifestyle interventions alone